Abstract
Construction and validation of a novel SUMOylation-related lncRNAs signature for predicting the prognosis, tumor immune microenvironment, and therapeutic sensitivity of lung adenocarcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have